MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,000K
Net Income
-$112,220K
Net Profit Margin
-11222.00%
EPS
-$1.77
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
1,000
-
0
-
Research and development
62,913
60,439
55,719
34,402
General and administrative
15,746
16,911
15,593
13,178
Acquired in-process research and development
30,000
-
166,672
5,000
Total operating expenses
108,659
77,350
237,984
52,580
Loss from operations
-107,659
-77,350
-237,984
-52,580
Interest expense on royalty obligation
6,837
6,263
-
-
Interest expense on senior secured term loan
1,720
368
-
-
Interest expense on royalty obligation
-
-
1,832*
-
Interest expense on convertible senior notes
1,745
-
-
-
Interest income
6,603
3,018
6,656*
-
Other income (expense), net
16
-24
-7,176
1,081
Total other income (expense), net
-3,683
-3,637
-2,352
1,081
Loss before income taxes
-111,342
-80,987
-240,336
-51,499
Income tax provision (benefit)
114
-
106
-
Net loss
-111,456
-80,987
-240,442
-51,499
Unrealized (loss) gain on investments
-780
-341
79
35
Foreign currency translation adjustment
16
28
-74
-10
Comprehensive loss
-112,220
-81,300
-240,437
-51,474
Basic EPS
-1.77
-1.46
-4.528
-1.22
Diluted EPS
-1.77
-1.46
-4.528
-1.22
Basic Average Shares
63,112,314
55,624,631
53,094,666
42,159,340
Diluted Average Shares
63,112,314
55,624,631
53,094,666
42,159,340
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$112,220K
(-113.92%↓ Y/Y)
Foreign currency
translation adjustment
$16K
(106.04%↑ Y/Y)
Net loss
-$111,456K
(-113.42%↓ Y/Y)
Unrealized (loss) gain on
investments
-$780K
(-2700.00%↓ Y/Y)
Loss before income
taxes
-$111,342K
(-113.29%↓ Y/Y)
Income tax provision
(benefit)
$114K
(470.00%↑ Y/Y)
Loss from operations
-$107,659K
(-95.17%↓ Y/Y)
Total other income
(expense), net
-$3,683K
(-224.43%↓ Y/Y)
Total revenue
$1,000K
Interest income
$6,603K
Other income
(expense), net
$16K
(-99.46%↓ Y/Y)
Total operating
expenses
$108,659K
(96.98%↑ Y/Y)
Interest expense on
royalty obligation
$6,837K
Interest expense on
convertible senior notes
$1,745K
Interest expense on
senior secured term...
$1,720K
Research and development
$62,913K
(46.22%↑ Y/Y)
Acquired in-process
research and development
$30,000K
General and
administrative
$15,746K
(29.75%↑ Y/Y)
Buy us a coffee
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO)